Schering Nitro-Dur Is One Target Of IG Medicaid Rebate Investigation
Executive Summary
Schering-Plough's Nitro-Dur (transdermal nitroglycerin) is one target of an investigation by the HHS Office of the Inspector General into the classification of brand name drugs for Medicaid